samedan logo
 
 
spacer
home > pmps > autumn 2020 > the vital role of cold chain technology
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Vital Role of Cold Chain Technology

Pharmaceutical manufacturers that are racing to develop vaccines for the coronavirus are already working behind the scenes to build the supply chains needed to deliver these precious treatments to billions of people, as quickly as possible. Rapidly distributing a safe and effective vaccine globally is likely to be one of the most significant challenges ever undertaken by supply chains.

Already stretched thin by the pandemic, manufacturers and freight companies have been facing problems ranging from shrinking capacity on container ships and cargo aircraft to a lack of visibility as to when a vaccine will arrive. For years, shippers have struggled to reduce cumbersome paperwork and manual processes by upgrading old technologies that, unless they are addressed soon, may slow the transport of fragile vials of medicine in unprecedented quantities. Supporting pharma manufacturers and distributors to ensure a strong continuum of efficient supply chain logistics will be essential.

Maintaining the strict temperature control of vaccines while they are distributed and stored to ensure they maintain their quality and integrity will pose significant challenges throughout the value chain. Complicating matters is that the vaccine candidates have differing storage requirements. One vaccine candidate must be stored at -20°C, while another must be maintained at -80°C. These will need different distribution and storage pathways, requiring additional planning and strategy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ada Palmadottir is Business Development Director at Controlant. With more than 20 years of experience in pharmacy, management, and technology, Ada has extensive international experience in sales, operations, and marketing, specifically in the areas of product, vertical alliance sales, and partnerships related to pharma products. She is a licensed and experienced pharmacist and earned a Master of Pharmacy from the University of Iceland and a Master of Business Administration from the Norwegian School of Management. Ada has been working with Controlant for the last eight years.
spacer
Ada Palmadottir
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Myonex Opens New Global Headquarters

Myonex, a leading global clinical trial supply company, marked the opening of its new global headquarters and US operational facility with a ribbon-cutting ceremony on the company’s 14-acre campus.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement